Detalhe da pesquisa
1.
Effects of serotonin 5-HT(3) receptor antagonists on CRF-induced abnormal colonic water transport and defecation in rats.
Eur J Pharmacol
; 587(1-3): 281-4, 2008 Jun 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-18456254
2.
Mucosal acid causes gastric mucosal microcirculatory disturbance in nonsteroidal anti-inflammatory drug-treated rats.
Eur J Pharmacol
; 554(1): 53-9, 2007 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-17112499
3.
Effect of ramosetron on conditioned emotional stress-induced colonic dysfunction as a model of irritable bowel syndrome in rats.
Eur J Pharmacol
; 573(1-3): 190-5, 2007 Nov 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-17658508
4.
Reduction in hepatic non-esterified fatty acid concentration after long-term treatment with atorvastatin lowers hepatic triglyceride synthesis and its secretion in sucrose-fed rats.
Biochim Biophys Acta
; 1580(2-3): 161-70, 2002 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-11880241
5.
Experimental model of postprandial hypertriglyceridemia in sucrose-fed rats and the effectiveness of atorvastatin in the model.
Metabolism
; 52(5): 609-15, 2003 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-12759892
6.
Atorvastatin increases hepatic fatty acid beta-oxidation in sucrose-fed rats: comparison with an MTP inhibitor.
Eur J Pharmacol
; 455(2-3): 161-7, 2002 Nov 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-12445582
7.
Antithrombotic and anticoagulant effects of direct factor Xa inhibitor darexaban in rat and rabbit models of venous thrombosis.
Eur J Pharmacol
; 699(1-3): 40-7, 2013 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23200896
8.
Darexaban: anticoagulant effects in mice and human plasma in vitro, antithrombotic effects in thrombosis and bleeding models in mice and effects of anti-inhibitor coagulant complex and recombinant factor VIIa.
Thromb Res
; 131(5): 450-6, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23591155
9.
ASP6537, a novel highly selective cyclooxygenase-1 inhibitor, exerts potent antithrombotic effect without "aspirin dilemma".
Thromb Res
; 132(1): 56-62, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23522855
10.
Plasma factor Xa inhibition can predict antithrombotic effects of oral direct factor Xa inhibitors in rabbit atherothrombosis models.
Thromb Haemost
; 108(5): 896-902, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23052641
11.
Biochemical and pharmacological profile of darexaban, an oral direct factor Xa inhibitor.
Eur J Pharmacol
; 673(1-3): 49-55, 2011 Dec 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-22040919
12.
Inhibitory effects of ramosetron, a potent and selective 5-HT3-receptor antagonist, on conditioned fear stress-induced abnormal defecation and normal defecation in rats: comparative studies with antidiarrheal and spasmolytic agents.
J Pharmacol Sci
; 106(2): 264-70, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18296863
13.
Evaluation of the pharmacological profile of ramosetron, a novel therapeutic agent for irritable bowel syndrome.
J Pharmacol Sci
; 104(3): 263-73, 2007 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-17652911
14.
[Pharmacological and clinical profile of ramosetron hydrochloride (Irribow), a novel therapeutic agent for irritable bowel syndrome with diarrhea].
Nihon Yakurigaku Zasshi
; 133(5): 281-91, 2009 May.
Artigo
em Japonês
| MEDLINE | ID: mdl-19443966